Thymoma medical therapy

Revision as of 20:53, 25 February 2014 by Amr Marawan (talk | contribs)
Jump to navigation Jump to search

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thymoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thymoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymoma medical therapy

CDC on Thymoma medical therapy

Thymoma medical therapy in the news

Blogs on Thymoma medical therapy

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Thymoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2]

Overview

Surgery is the main stay of therapy. Chemo and radio therapy are used as adjuvant ot neoadjuvant therapies. Sometimes they are used prior to surgery to make the tumor resectable. Signs and symptoms of myasthenia gravis should be evaluated before surgery and medically controlled.

Medical Therapy

[1]

Radiotherapy

Radiotherapy is used in unresectable thymoma or incompletely resected invasive thymoma. The dose and fractionation schemes of RT depend on the indication of the radiation and the completeness of surgical resection.[2]

Chemotherapy

It is used in locally advanced thymomas then re-evaluated for resectability. In cases of isolated solitary metastasis, we either start with chemotherapy then re-evaluate for surgery or start by surgery. It is also used if there is evidence of distant metastasis. Most of the chemotherapy being designed is based on cisplatin and anthracyclines.

Corticosteroids

Corticosteroids may be used in unresectable tumors that have been refractory to radiation therapy leading to transient partial responses.[3] Similar to the effects of ageing and stress, steroids increase thymic fat and connective tissue and decrease corticomedullar differentiation. Therefore in WHO subtypes A and B thymoma, corticosteroids produce tumour size reduction due to lymphocyte depletion.[4]

References

  1. "https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf" (PDF). External link in |title= (help)
  2. "https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf" (PDF). External link in |title= (help)
  3. "http://www.cancernet.nci.nih.gov/cancertopics/types/thymoma". External link in |title= (help)
  4. "Octreotide alone or with prednisone in patients... [J Clin Oncol. 2004] - PubMed - NCBI".